Hendel Psoriasis, Eczema, Seborrhea
FDA Label NDC 62795-1126

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Hendel Psoriasis, Eczema, Seborrhea (NDC 62795-1126). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings, uses, keep out of reach of children, directions, indications, inactive ingredient, ingredients, dr. hendel psoriasis, eczema, seborrhea, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if sensitivity to Psoriasis, Eczema, Seborrhea Relief or any of its ingredients exists. In case of accidental overdose, contact a Poison Control Center immediately.

Uses

• Red scaly patches on skin
• Itchy
• Flaky skin
• Skin inflammation

Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN

Directions

Adults 18 and over: 1 tablet sublingually or dissolved completely in mouth 2 to 3 times per day or as directed by a physician

Indications

Psoriasis, Eczema, Seborrhea Relief

Inactive Ingredient

Lactose, Magnesium stearate

Ingredients

Each tablet contains equal parts of Petroleum 6X; Graphites 12X; Hepar sulphuris calcareum 12X; Sepia 12X; Sulphur 12X; Thuja occidentalis 12X.

* Please review the disclaimer below.